Live Breaking News & Updates on ஆயுதக் களஞ்சியம் மூலதனம் மேலாண்மை

InterShunt Announces Equity Financing
Share this article
Share this article
ST. LOUIS, Jan. 11, 2021 /PRNewswire/  InterShunt Technologies, Inc., an early-stage medical device company developing a novel catheter-based solution to reduce left atrial pressure in heart failure patients, announced today the completion of an equity financing. Funding will be used to support the research and development of the Percutaneous Atrial Shunt Catheter System (PAS-C™ System).  The round was led by Solas BioVentures with participation from Arsenal Capital Management and a select group of industry executives.
David Adair, MD, MBA, Managing Partner of Solas BioVentures stated, InterShunt s innovative and differentiated approach to create an interatrial shunt has the potential to provide significant clinical benefit in a space that has limited options. The ability to create a shunt without energy or hardware is attractive. Leaving nothing behind allows the body the best chanc ....

United States , Solas Bioventures , Harlee Sorkin , David Adair , Intershunt Technologies Inc , Investment Team , Intershunt Technologies , Percutaneous Atrial Shunt Catheter System , Arsenal Capital Management , Managing Partner , Heart Failure , Life Science , Capital Management , ஒன்றுபட்டது மாநிலங்களில் , டேவிட் அடர் , முதலீடு அணி , ஆயுதக் களஞ்சியம் மூலதனம் மேலாண்மை , நிர்வகித்தல் கூட்டாளர் , இதயம் தோல்வி , வாழ்க்கை அறிவியல் , மூலதனம் மேலாண்மை ,